Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
Acurx Pharmaceuticals, Inc.
- Last sale
- Oct 6, 2026 · -1.50%
- Market cap
- $6.90M
- 5.27M shares
- Filings
- 243
Price
Oct 6, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,834,506 | reported | |
| FY 2024 | 2024-12-31 | $5,403,836 | reported | |
| FY 2023 | 2023-12-31 | $6,043,597 | reported | |
| FY 2022 | 2022-12-31 | $4,754,271 | reported | |
| FY 2021 | 2021-12-31 | $2,030,177 | reported | |
| FY 2020 | 2020-12-31 | $2,202,979 | reported |
Acurx Pharmaceuticals, Inc. · CIK 1736243 · Engraved from SEC EDGAR
